SonALAsense
0 followers
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors. It utilizes MRI-guided focused ultrasound (the device) in combination with aminolevulinic acid (a drug) to selectively target and kill tumor cells. Their use of an MRI-guided... Read more
Org chart
Mark de Souza
President and CEO
Mark de Souza
Collapse
April Freeman, MPH
Head, Global Patient Advocacy and Engagement
Joanne L.
Senior Vice President, Regulatory Affairs
Nandini Kandolha
Chief Financial Officer & Chief Operations Officer
Stuart Marcus, MD, PhD
Founder And Chief Scientific Officer
Dr. Corina Andresen
Vice President Clinical Development, Oncology, SonALASense
Ely Benaim
Chief Medical Officer and EVP of Development
